D27.9
Benign neoplasm of unspecified ovary
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign neoplasm of the ovary refers to a non-cancerous growth that develops in ovarian tissue. When the specific type of tumor cannot be identified, it is classified under the code D27.9 in the ICD-10 system. Such growths are generally slow-growing and do not invade neighboring tissues or metastasize to other parts of the body, distinguishing them from malignant ovarian tumors. Understanding this condition can help in managing and monitoring ovarian health effectively.
Causes & Symptoms
Clinical Causes: Genetic predisposition or hereditary factors Hormonal imbalances that influence ovarian cell growth Environmental exposures, although specific links are not well established Previous ovarian injuries or surgeries, which may alter tissue growth Age-related changes, especially in women approaching menopause
Key Symptoms: Often no noticeable symptoms in early stages Pelvic discomfort or heaviness Fullness or bloating in the abdomen Changes in menstrual cycles or irregular periods Rarely, pain during sexual intercourse
Diagnostic & Treatment
Diagnosis Path: Diagnosis of a benign ovarian neoplasm typically involves imaging tests such as ultrasound, which can visualize ovarian masses. Sometimes, additional imaging like MRI or CT scans is used for clarification. Blood tests may also be performed to measure tumor markers, although these are more relevant in suspected malignant cases. Confirmatory diagnosis often requires surgical removal and histopathological examination of the cyst or tumor tissue to determine its benign nature and classify it appropriately.
Treatment Protocols: Treatment strategies depend on the size, location, and symptoms associated with the ovarian growth. Options include:
Clinical Advice & FAQs
Billing Guidance
Is D27.9 a billable ICD-10 code?
Yes, D27.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D27.9?
Clinical documentation must specify the nature of Benign neoplasm of unspecified ovary and any associated comorbidities for accurate reporting.
Cite this Clinical Reference